The neurological device market encompasses a wide range of devices that are used to regulate the body’s nervous system. iData Research analysts have a great deal of experience delving deep into this market to deliver industry-leading reports to our clients, and this information helps executives formulate key decisions.
We offer unsurpassed neurology market analysis that highlights both growth opportunities as well as potential limiting factors.
By 2020, the global neuromodulation device market size was valued at nearly $4.4 billion, with over 230,000 neuromodulation procedures performed every year. The neuromodulation devices market growth is expected to be around 7.6% allowing the market size to approach $7.3 billion in 2026. Throughout this medical market research, we analyzed 13 neuromodulation device companies across
By 2020, the U.S. neurology devices market size was valued at $4.8 billion, and there were over 726,000 neurological procedures performed. The market size is expected to increase at a growth rate of 6.9% to reach $7.6 billion in 2026. Throughout this medical market research, we analyzed 44 neurological device companies across the United States
Industry Trends One of the major drivers for the neurological devices market is the patient and physicians demand for minimally invasive procedures. This has been driving the growth in aspiration thrombectomy and neurovascular stenting and the decline of and aneurysm clipping procedures treatments. With the growth in these markets, the market value for ubiquitous neurovascular
Industry Trends The shift from open cavity procedures to minimally invasive procedures has already occurred within the United States, Australia and Europe. For hospitals to attract top talent, they must be equipped with the latest in high-tech equipment and facilities in order to increase efficiency for the surgeon. Incorporating surgical navigation and robotic systems into
Overall, the U.S. surgical robotics market was valued at $X billion in 2018. This is expected to increase over the forecast period to reach $X billion in 2025. On the other hand, the surgical navigation market was valued at $X million in 2018. This value is projected to increase over the forecast period at a
Industry Trends The neurovascular devices market includes three market segments: neurovascular catheters, neurovascular guidewires, and neurovascular stents. Neurovascular catheters, also known as microcatheters, are a type of catheter small enough to be used in neurovascular procedures. Microcatheters are designed with several properties in mind: hydrophilic coating, softness, trackability and stability. Of the devices in this
Neurosurgery navigation, or neuronavigation, requires the use of computer-assisted technologies to guide or navigate neurosurgeons during cranial procedures. This type of surgery evolved from stereotactic surgery, which gained popularity during the 1940s. Stereotaxy was developed to better locate specific small targets within the patient using a three-dimensional coordinate system. The current form of neuronavigation was established in the 1990s but has significantly improved due to the implementation of new neuro-imaging technologies, real-time imaging capabilities, advancements in 3D localization and visualization, intraoperative capabilities, robotics and dramatic improvements in software. Neuronavigation has been at the forefront of image guided surgery (IGS) and computer assisted surgery (CAS) due to the level of sophistication associated with the procedures. It is continually evolving with the introduction of new technologies as well as the increased number of procedures for which it can be used. An example of a new technology emerging in this field is surgical virtualization. Neurosurgeons can essentially perform a trial virtual surgery using software which creates a 3D model of the surgical area, allowing them to assess the possible complications that may arise during the surgery and try alternative approaches to determine which will result in the most accurate results.
The market for spine navigation systems, or spinal image guided surgery (IGS) systems, is closely linked to that of neurosurgical IGS systems. There are relatively few dedicated IGS systems for spinal procedures. Most spinal IGS procedures are performed using neurosurgical IGS systems with spinal software applications. Because spinal and neurosurgical operations are often performed by the same surgeons, this arrangement has worked well so far. Certain spinal procedures may require specialized instruments; however, these disposable instruments can be used with non-specialized systems that have the appropriate software. Many spinal IGS systems can be used to assist in trauma procedures once equipped with the right software and accessories. Spinal conditions treated with IGS include fractures, metastasis, spinal slip disc and spinal curvature. Spinal imaging software allows surgeons to perform on the thoracic and lumbar regions of the spine, while many have pelvic trauma applications. Recently, there has been a push to develop more dedicated spinal IGS and robotic systems that would be better suited to strictly spinal or trauma surgeries.
Surgical robotics has tremendous potential to increase the effectiveness of existing procedures and to facilitate novel procedure types. The surgical robotics industry is, in many ways, still in its infancy, with more products in development than currently commercially available on the market. Most new surgical robotic systems are designed for highly specialized medical applications, which is a major draw-back for most facilities. The types of surgical robotic assisted systems covered in this section are: minimally invasive surgery robotic systems, orthopedic robotic systems, spinal robotic systems, neurosurgery robotic systems, robotic catheters and radiosurgery robotic systems.
An aneurysm clip is a permanent fixture in the brain that resembles a tiny coil-spring clothespin made of titanium or a cobalt chromium nickel alloy. Biocompatible aneurysm clips used in the neurosurgical field are available in a variety of shapes and sizes, with known closing pressures. Aneurysm clips are placed at the neck of an aneurysm and serve to isolate the thin-walled aneurysm from arterial flow without obstructing the parent artery or other perforating arteries. Aneurysms are a localized, blood-filled balloon-bulge in the wall of a blood vessel. As an aneurysm grows, it becomes thinner and more prone to leaking or rupture. If this occurs, blood is released into the spaces around the brain, leading to a subarachnoid hemorrhage (SAH).
Balloon occlusion devices have inflatable balloon devices at their distal end which can be expanded to occlude an artery. Balloon occlusion devices serve a number of purposes in neurovascular procedures. They can be used to assist detachable coil procedures, similarly to stents, however these devices are temporary. In these cases they are being used to aid in the treatment of aneurysms, AVMs or fistulas. When using detachable coils there is a risk of the coils blocking flow of the parent artery if they occlude the lumen of the artery as well. In order to minimize this risk, the balloon is inflated inside the parent artery prior to the insertion of coils so that they can be packed tighter inside the aneurysm without the danger of them protruding into the lumen. A study looking at this technique in anterior aneurysms found that there was a lower complication rate with balloon assisted coiling in comparison to coiling alone however other studies have found the opposite therefore further studies are required. In some cases, balloon catheters can also be used for the placement of stents. There are a number of factors that could impact the choice to use this device for aneurysm treatment such as the clinical situation, physicians preference, and the morphology of the aneurysm. It is worth noting that the ASP of these devices is considerably less than stents which could impact device preference as well.
Devices in the cerebrospinal fluid (CSF) management market are mainly used for the treatment of hydrocephalus. Hydrocephalus, or water on the brain, refers to an abnormal buildup of CSF in the brains ventricles. Under normal biological conditions, equilibrium between the production, circulation and absorption of CSF is maintained in the ventricular cavities of the brain as CSF is continually drained away into the circulatory system. Hydrocephalus can result when absorption of fluid into the bloodstream is blocked which leads to an accumulation of CSF. This condition can result in increased intracranial pressure inside of the skull and can lead to tunnel vision, mental disability, progressive enlargement of the head and even death. Symptoms due to the increased intracranial pressure include headaches, nausea, vomiting, papilledema, coma or sleepiness. Further elevation of intracranial pressure can result in uncal and/or cerebellar herniation.
Detachable coil embolization is a minimally invasive method of treating brain aneurysms and cerebral blood vessel malformations. The detachable coil embolization treatment of cerebral aneurysms is less invasive and requires less recovery time than open surgery. An aneurysm is a weakened area in the wall of an artery in the brain. This area bulges in the artery and if it ruptures it can lead to a bleed in the brain and cause stroke, brain damage and even death. Interventional neuroradiologists will typically perform the detachable coil embolization process to alleviate dangers associated with aneurysms.
An intrathecal pump is an implantable medical device that delivers medication to the intrathecal space surrounding the spinal cord. The drug pump reduces the reliance of patients on oral or intravenous medications and can minimize the associated side effects while controlling their symptoms. Lower doses of medications are generally required since the drug delivery is more targeted. Before a pump is implanted into the patient, the therapeutic effect of the intrathecal opioid therapy is tested with an external pump; the pump is not implanted if there are no clear and satisfactory effects in the trial application.
Liquid embolics currently on the market include N-butyl cyanoacrylate (NBCA) (TRUFILL®) and an ethylene-vinyl alcohol copolymer (Onyx®). These agents are injected through microcatheters and act like glue in abnormal blood vessels. When they contact blood they solidify and obstruct the vessel lumen therefore blocking the flow of blood through malformed blood vessels and reducing the risk of rupture. The surgeon performing the procedure must flush the catheter before and after injecting the NBCA to prevent the liquid agent from sticking to the catheter. Thus this procedure requires a highly skilled physician. This is often done prior to the removal of these vessels in order to simplify the surgical procedure.
Ischemic Stroke is caused by an obstruction within a blood vessel that is supplying blood to the brain. This is often caused by blood clots but can also be caused by other substances like plaque. The gold standard treatment for strokes for many years has been the administration of clot dissolving or clot busting medication called tissue plasminogen activator (tPA). This type of drug must be administered as soon as possible, with a four hour window from symptom onset, to increase chances of recovery. A significant number of patients do not get to healthcare facilities quickly enough to meet that window and even some of those who do, later experience hemorrhagic complications from the medication. It is very effective for smaller clots but often fails to break up larger clots. Some patients cannot receive tPA, in which cases physicians rely on antiplatelet or anticoagulant medicine to ensure blood clots do not get larger.